A Changing World Pharmaceutical Market

21 May 1995

Worldwide, the pharmaceutical market in 1994 was valued by Euromonitor at around $259 billion at manufacturers' selling prices, with prescription drugs representing $222 billion sales and over-the-counter medicines $37 billion.

As far as prescription drugs alone are concerned, turnover increased by 40.5% between 1990 and 1994, with North America continuing to hold the leading share. The three major regions - North America (31%), Japan (23%) and Europe (29%) - dominate the world market, with a combined 83% share of total sales. Latin America follows with 6%, leaving just 11% for the rest of the world.

Rx Sales By Category Category % Market Share Cardiovasculars 21% Anti-infectives 15% Gastrointestinals 14% Central nervous system 9% Respiratory 6% Musculoskeletal 5% Anticancer agents 5% Endocrine system 5% Dermatologicals 4% Others 16% Source: Euromonitor

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight